参考文献/References:
[1] Bendotti C,Carri MT.Lessons from models of SOD1-linked familial ALS[J].Trends in Molecular Medicine,2004,10(8):393-400.
[2] White MA,Sreedharan J.Amyotrophic lateral sclerosis:recent genetic highlights[J].Current Opinion in Neurology,2016,29(5):557-564.
[3] Manfredi G,Kawamata H.Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis[J].Neurobiology of Disease,2016,90(6):35-42.
[4] Lee S,Shang Y,Redmond SA,et al.Activation of HIPK2 promotes ER Stress-Mediated neurodegeneration in amyotrophic lateral sclerosis[J].Neuron,2016,91(1):41-55.
[5] Fifita JA,Williams KL,Sundaramoorthy V,et al.A novel amyotrophic lateral sclerosis mutation in OPTN induces ER stress and Golgi fragmentation in vitro,Amyotrophic lateral sclerosis&frontotemporal degeneration[Z],2016:1-8.
[6] Cai Y,Arikkath J,Yang L,et al.Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders[J].Autophagy,2016,12(2):225-244.
[7] Jiang HQ,Ren M,Jiang HZ,et al.Guanabenz delays the onset of disease symptoms,extends lifespan,improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis,Neuroscience,277c[Z],2014:132-138.
[8] Wang L,Popko B,Tixier E,et al.Guanabenz,which enhances the unfolded protein response,ameliorates mutant SOD1-induced amyotrophic lateral sclerosis[J].Neurobiology of Disease,2014,71(11):317-324.
[9] Tanaka H,Shimazawa M,Kimura M,et al.The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis,Scientific reports[J].Scientific Reports,2012,2(2):573.
[10] Chi L,Ke Y,Luo C,et al.Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo[J].Neuroscience,2007,144(3):991-1003.
[11] Tsaytler P,Harding HP,Ron D,et al.Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis[J].Science,2011,332(6025):91-94.
[12] Roussel BD,Kruppa AJ,Miranda E,et al.Endoplasmic reticulum dysfunction in neurological disease[J].Lancet neurology,2013,12(1):105-118.
[13] Holmes B,Brogden RN,Heel RC,et al.A review of its pharmacodynamic properties and therapeutic efficacy in hypertension[J].Drugs,1983,26(3):212-229.
[14] Bidhendi EE,Bergh J,Zetterstrom P,et al.Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease[J].The Journal of Clinical Investigation,2016,126(6):2249-2253.